Pakistan’s drug regulatory agency has approved final-phase testing of a Chinese-made vaccine against Covid-19.
In a statement on Monday (Aug 17), the state-run National Institute of Health said the approval to carry out advanced clinical trials for potential Covid-19 was granted by Drug Regulatory Authority of Pakistan.
It said the phase-3 clinical trials for a candidate vaccine against the new virus will be conducted at the country’s main health facilities.
It said the vaccine was produced by CanSinoBio, a China-based vaccine developer and Beijing Institute of Biotechnology.
Pakistan, which has witnessed a steady decline in fatalities from the new virus, reported only 15 new Covid-19 deaths and 617 new cases in the past 24 hours. It has reported 289,832 cases since February when the first infection was detected in the country. (AP)
